Companies Dominating the Atrial Fibrillation Surgery Landscape
- Abbott Laboratories.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AtriCure, Inc.,
- Biosense Webster, Inc.,
- Boehringer Ingelheim GmbH
- Boston Scientific Corporation
- Bristol-Myers Squibb Corporation
- CardioFocus, Inc.,
- Endoscopic Technologies, Inc.,
- Sanofi Aventis,
- Johnson and Johnson Ltd.,
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Atrial Fibrillation Surgery Market in 2025 is estimated at USD 4.68 billion.
The global market size was valued at around USD 4.1 billion in 2024 and is projected to grow at a CAGR of more than 17.7%, reaching USD 34.11 billion revenue by 2037.
North America is forecast to yield USD 10.92 billion by 2037, driven by technological advancements in atrial fibrillation surgery and the aging population with cardiac conditions.
The major players in the market include Abbott Laboratories., AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd.
